140 related articles for article (PubMed ID: 15054876)
1. Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.
Strieth S; Eichhorn ME; Sauer B; Schulze B; Teifel M; Michaelis U; Dellian M
Int J Cancer; 2004 May; 110(1):117-24. PubMed ID: 15054876
[TBL] [Abstract][Full Text] [Related]
2. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.
Schmitt-Sody M; Strieth S; Krasnici S; Sauer B; Schulze B; Teifel M; Michaelis U; Naujoks K; Dellian M
Clin Cancer Res; 2003 Jun; 9(6):2335-41. PubMed ID: 12796403
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin.
Strieth S; Eichhorn ME; Werner A; Sauer B; Teifel M; Michaelis U; Berghaus A; Dellian M
Clin Cancer Res; 2008 Jul; 14(14):4603-11. PubMed ID: 18628475
[TBL] [Abstract][Full Text] [Related]
4. Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes.
Strieth S; Nussbaum CF; Eichhorn ME; Fuhrmann M; Teifel M; Michaelis U; Berghaus A; Dellian M
Int J Cancer; 2008 Jan; 122(2):452-60. PubMed ID: 17918179
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.
Kunstfeld R; Wickenhauser G; Michaelis U; Teifel M; Umek W; Naujoks K; Wolff K; Petzelbauer P
J Invest Dermatol; 2003 Mar; 120(3):476-82. PubMed ID: 12603862
[TBL] [Abstract][Full Text] [Related]
6. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels.
Krasnici S; Werner A; Eichhorn ME; Schmitt-Sody M; Pahernik SA; Sauer B; Schulze B; Teifel M; Michaelis U; Naujoks K; Dellian M
Int J Cancer; 2003 Jul; 105(4):561-7. PubMed ID: 12712451
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging.
Eichhorn ME; Becker S; Strieth S; Werner A; Sauer B; Teifel M; Ruhstorfer H; Michaelis U; Griebel J; Brix G; Jauch KW; Dellian M
Cancer Biol Ther; 2006 Jan; 5(1):89-96. PubMed ID: 16357513
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic combination tumor therapy blocking alpha(v)-integrins and VEGF-receptor-2 increases therapeutic effects in vivo.
Strieth S; Eichhorn ME; Sutter A; Jonczyk A; Berghaus A; Dellian M
Int J Cancer; 2006 Jul; 119(2):423-31. PubMed ID: 16477628
[TBL] [Abstract][Full Text] [Related]
9. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
10. Static magnetic fields impair angiogenesis and growth of solid tumors in vivo.
Strelczyk D; Eichhorn ME; Luedemann S; Brix G; Dellian M; Berghaus A; Strieth S
Cancer Biol Ther; 2009 Sep; 8(18):1756-62. PubMed ID: 19633422
[TBL] [Abstract][Full Text] [Related]
11. Protamine enhances uptake of cationic liposomes in angiogenic microvessels.
Eichhorn ME; Strieth S; Krasnici S; Sauer B; Teifel M; Michaelis U; Naujoks K; Dellian M
Angiogenesis; 2004; 7(2):133-41. PubMed ID: 15516834
[TBL] [Abstract][Full Text] [Related]
12. Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel.
Gellrich D; Becker S; Strieth S
Cancer Lett; 2014 Feb; 343(1):107-14. PubMed ID: 24075957
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer.
Bode C; Trojan L; Weiss C; Kraenzlin B; Michaelis U; Teifel M; Alken P; Michel MS
Oncol Rep; 2009 Aug; 22(2):321-6. PubMed ID: 19578772
[TBL] [Abstract][Full Text] [Related]
14. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model.
Abu-Lila A; Suzuki T; Doi Y; Ishida T; Kiwada H
J Control Release; 2009 Feb; 134(1):18-25. PubMed ID: 19010364
[TBL] [Abstract][Full Text] [Related]
17. Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study.
Pahernik S; Harris AG; Schmitt-Sody M; Krasnici S; Goetz AE; Dellian M; Messmer K
Br J Cancer; 2002 May; 86(10):1622-7. PubMed ID: 12085213
[TBL] [Abstract][Full Text] [Related]
18. Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.
Eichhorn ME; Ischenko I; Luedemann S; Strieth S; Papyan A; Werner A; Bohnenkamp H; Guenzi E; Preissler G; Michaelis U; Jauch KW; Bruns CJ; Dellian M
Int J Cancer; 2010 Mar; 126(5):1235-45. PubMed ID: 19697323
[TBL] [Abstract][Full Text] [Related]
19. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
[TBL] [Abstract][Full Text] [Related]
20. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
